Inhibition of A431 cell proliferation
|
Homo sapiens
|
0.083
ug.mL-1
|
|
Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting
|
None
|
7.4
nM
|
|
Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography
|
None
|
1.5
nM
|
|
Irreversible inhibition of formation of phosphorylated EGFR enzyme in A431 cells 8 hr after washing cells free of the inhibitor
|
None
|
80.0
%
|
|
Inhibition of autophosphorylation of ERBB2 receptor kinase in MDA-MB 453 cells
|
None
|
9.0
nM
|
|
Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation
|
Homo sapiens
|
74.0
nM
|
|
Inhibition of human epidermal growth factor receptor-2 autophosphorylation
|
Homo sapiens
|
529.0
nM
|
|
Inhibition of SW-620 cell proliferation
|
Homo sapiens
|
1.45
ug.mL-1
|
|
Inhibition of SKBR-3 cell proliferation
|
Homo sapiens
|
0.102
ug.mL-1
|
|
Average Binding Constant for BTK; NA=Not Active at 10 uM
|
Homo sapiens
|
750.0
nM
|
|
Average Binding Constant for EPHA6; NA=Not Active at 10 uM
|
Homo sapiens
|
72.0
nM
|
|
Average Binding Constant for SLK; NA=Not Active at 10 uM
|
Homo sapiens
|
440.0
nM
|
|
Average Binding Constant for EPHA4; NA=Not Active at 10 uM
|
Homo sapiens
|
310.0
nM
|
|
Average Binding Constant for EPHA5; NA=Not Active at 10 uM
|
Homo sapiens
|
270.0
nM
|
|
Average Binding Constant for EPHA8; NA=Not Active at 10 uM
|
Homo sapiens
|
790.0
nM
|
|
Average Binding Constant for EPHA3; NA=Not Active at 10 uM
|
Homo sapiens
|
650.0
nM
|
|
Average Binding Constant for STK10; NA=Not Active at 10 uM
|
Homo sapiens
|
430.0
nM
|
|
Average Binding Constant for RIPK2; NA=Not Active at 10 uM
|
Homo sapiens
|
330.0
nM
|
|
Average Binding Constant for GAK; NA=Not Active at 10 uM
|
Homo sapiens
|
44.0
nM
|
|
Average Binding Constant for LYN; NA=Not Active at 10 uM
|
Homo sapiens
|
780.0
nM
|
|
Average Binding Constant for LCK; NA=Not Active at 10 uM
|
Homo sapiens
|
560.0
nM
|
|
Average Binding Constant for ERBB2; NA=Not Active at 10 uM
|
Homo sapiens
|
8.4
nM
|
|
Average Binding Constant for EGFR; NA=Not Active at 10 uM
|
Homo sapiens
|
1.4
nM
|
|
Average Binding Constant for ABL1; NA=Not Active at 10 uM
|
Homo sapiens
|
340.0
nM
|
|
Average Binding Constant for ABL1(Q252H); NA=Not Active at 10 uM
|
Homo sapiens
|
470.0
nM
|
|
Average Binding Constant for ABL1(H396P); NA=Not Active at 10 uM
|
Homo sapiens
|
320.0
nM
|
|
Average Binding Constant for ABL1(M351T); NA=Not Active at 10 uM
|
Homo sapiens
|
560.0
nM
|
|
Average Binding Constant for ABL1(T315I); NA=Not Active at 10 uM
|
Homo sapiens
|
290.0
nM
|
|
Average Binding Constant for ABL1(Y253F); NA=Not Active at 10 uM
|
Homo sapiens
|
420.0
nM
|
|
Average Binding Constant for SRC; NA=Not Active at 10 uM
|
Homo sapiens
|
760.0
nM
|
|
Inhibition of EGFR
|
None
|
2.3
nM
|
|
Inhibition of HER2
|
None
|
48.0
nM
|
|
Inhibition of HER4
|
None
|
14.0
nM
|
|
Inhibition of Blk
|
None
|
50.0
nM
|
|
Inhibition of Bmx
|
None
|
586.0
nM
|
|
Inhibition of Btk
|
None
|
185.0
nM
|
|
Inhibition of Blk expressed in mouse BAF3 cells assessed as cytotoxicity
|
None
|
29.0
nM
|
|
Inhibition of Bmx expressed in mouse BAF3 cells assessed as cytotoxicity
|
None
|
62.0
nM
|
|
Inhibition of EGFR by HTRF assay
|
None
|
5.0
nM
|
|
Inhibition of ERBb2 by HTRF assay
|
None
|
80.0
nM
|
|
Antiproliferative activity against human HN5 cells overexpressing EGFR after 3 days by methylene blue staining
|
Homo sapiens
|
50.0
nM
|
|
Antiproliferative activity against human BT474 cells overexpressing ERBb2 after 3 days by methylene blue staining
|
Homo sapiens
|
10.0
nM
|
|
Binding constant for ABL1(H396P) kinase domain
|
Homo sapiens
|
500.0
nM
|
|
Binding constant for EGFR kinase domain
|
Homo sapiens
|
0.19
nM
|
|
Binding constant for EGFR(G719C) kinase domain
|
Homo sapiens
|
0.13
nM
|
|
Binding constant for RET(M918T) kinase domain
|
Homo sapiens
|
840.0
nM
|
|
Binding constant for DDR1 kinase domain
|
Homo sapiens
|
400.0
nM
|
|
Binding constant for EGFR(G719S) kinase domain
|
Homo sapiens
|
0.19
nM
|
|
Binding constant for FLT3(D835Y) kinase domain
|
Homo sapiens
|
730.0
nM
|
|
Binding constant for TXK kinase domain
|
Homo sapiens
|
700.0
nM
|
|
Binding constant for ABL1(M351T) kinase domain
|
Homo sapiens
|
640.0
nM
|
|
Binding constant for ABL1(Q252H) kinase domain
|
Homo sapiens
|
200.0
nM
|
|
Binding constant for EGFR(L858R) kinase domain
|
Homo sapiens
|
0.24
nM
|
|
Binding constant for BLK kinase domain
|
Homo sapiens
|
45.0
nM
|
|
Binding constant for EGFR(L747-E749del, A750P) kinase domain
|
Homo sapiens
|
0.17
nM
|
|
Binding constant for EGFR(L747-S752del, P753S) kinase domain
|
Homo sapiens
|
0.26
nM
|
|
Binding constant for full-length MKNK1
|
Homo sapiens
|
260.0
nM
|
|
Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain
|
Homo sapiens
|
630.0
nM
|
|
Binding constant for LCK kinase domain
|
Homo sapiens
|
320.0
nM
|
|
Binding constant for TGFBR2 kinase domain
|
Homo sapiens
|
800.0
nM
|
|
Binding constant for ABL1(Y253F) kinase domain
|
Homo sapiens
|
730.0
nM
|
|
Binding constant for ABL2 kinase domain
|
Homo sapiens
|
870.0
nM
|
|
Binding constant for EGFR(E746-A750del) kinase domain
|
Homo sapiens
|
0.26
nM
|
|
Binding constant for EGFR(S752-I759del) kinase domain
|
Homo sapiens
|
0.19
nM
|
|
Binding constant for ERBB2 kinase domain
|
Homo sapiens
|
87.0
nM
|
|
Binding constant for ERBB4 kinase domain
|
Homo sapiens
|
29.0
nM
|
|
Binding constant for LYN kinase domain
|
Homo sapiens
|
810.0
nM
|
|
Binding constant for GAK kinase domain
|
Homo sapiens
|
100.0
nM
|
|
Binding constant for ABL1(T315I) kinase domain
|
Homo sapiens
|
550.0
nM
|
|
Binding constant for EGFR(L747-T751del,Sins) kinase domain
|
Homo sapiens
|
0.26
nM
|
|
Binding constant for EGFR(L861Q) kinase domain
|
Homo sapiens
|
0.22
nM
|
|
Binding constant for RIPK2 kinase domain
|
Homo sapiens
|
300.0
nM
|
|
Binding constant for EPHA6 kinase domain
|
Homo sapiens
|
270.0
nM
|
|
Binding constant for MEK5 kinase domain
|
None
|
60.0
nM
|
|
Binding constant for MKK7 kinase domain
|
None
|
110.0
nM
|
|
Binding constant for LRRK2 kinase domain
|
None
|
500.0
nM
|
|
Binding constant for EPHA6 kinase domain
|
None
|
270.0
nM
|
|
Binding constant for QSK kinase domain
|
None
|
700.0
nM
|
|
Binding constant for JAK3(JH1domain-catalytic) kinase domain
|
None
|
630.0
nM
|
|
Binding constant for KIT(A829P) kinase domain
|
None
|
700.0
nM
|
|
Binding constant for KIT(D816H) kinase domain
|
None
|
600.0
nM
|
|
Binding constant for MET(Y1235D) kinase domain
|
None
|
830.0
nM
|
|
Binding constant for ERBB2 kinase domain
|
None
|
56.0
nM
|
|
Binding constant for ERBB4 kinase domain
|
None
|
6.5
nM
|
|
Binding constant for MKNK1 kinase domain
|
None
|
260.0
nM
|
|
Binding constant for IRAK1 kinase domain
|
None
|
450.0
nM
|
|
Binding constant for BLK kinase domain
|
None
|
45.0
nM
|
|
Binding constant for CSNK1E kinase domain
|
None
|
420.0
nM
|
|
Binding constant for DDR1 kinase domain
|
None
|
400.0
nM
|
|
Binding constant for ERBB3 kinase domain
|
None
|
210.0
nM
|
|
Binding constant for LYN kinase domain
|
None
|
810.0
nM
|
|
Binding constant for TGFBR2 kinase domain
|
None
|
800.0
nM
|
|
Binding constant for TXK kinase domain
|
None
|
700.0
nM
|
|
Binding constant for RIPK2 kinase domain
|
None
|
300.0
nM
|
|
Binding constant for FLT3(D835Y) kinase domain
|
None
|
730.0
nM
|
|
Binding constant for FLT3(R834Q) kinase domain
|
None
|
490.0
nM
|
|
Binding constant for EPHB6 kinase domain
|
None
|
640.0
nM
|
|
Binding constant for MAP4K2 kinase domain
|
None
|
330.0
nM
|
|
Binding constant for ABL1(E255K)-phosphorylated kinase domain
|
None
|
30.0
nM
|
|
Binding constant for ABL1(F317L)-phosphorylated kinase domain
|
None
|
91.0
nM
|
|
Binding constant for ABL1(H396P)-non phosphorylated kinase domain
|
None
|
46.0
nM
|
|
Binding constant for ABL1(H396P)-phosphorylated kinase domain
|
None
|
57.0
nM
|
|
Binding constant for ABL1(M351T)-phosphorylated kinase domain
|
None
|
38.0
nM
|
|
Binding constant for ABL1(Q252H)-non phosphorylated kinase domain
|
None
|
91.0
nM
|
|
Binding constant for ABL1(Q252H)-phosphorylated kinase domain
|
None
|
22.0
nM
|
|
Binding constant for ABL1(T315I)-non phosphorylated kinase domain
|
None
|
690.0
nM
|
|
Binding constant for ABL1(T315I)-phosphorylated kinase domain
|
None
|
69.0
nM
|
|
Binding constant for ABL1(Y253F)-phosphorylated kinase domain
|
None
|
42.0
nM
|
|
Binding constant for ABL1-non phosphorylated kinase domain
|
None
|
210.0
nM
|
|
Binding constant for ABL1-phosphorylated kinase domain
|
None
|
30.0
nM
|
|
Binding constant for ABL2 kinase domain
|
None
|
870.0
nM
|
|
Binding constant for EGFR kinase domain
|
None
|
0.19
nM
|
|
Binding constant for EGFR(E746-A750del) kinase domain
|
None
|
0.26
nM
|
|
Binding constant for EGFR(G719C) kinase domain
|
None
|
0.13
nM
|
|
Binding constant for EGFR(G719S) kinase domain
|
None
|
0.19
nM
|
|
Binding constant for EGFR(L747-E749del, A750P) kinase domain
|
None
|
0.17
nM
|
|
Binding constant for EGFR(L747-S752del, P753S) kinase domain
|
None
|
0.26
nM
|
|
Binding constant for EGFR(L747-T751del,Sins) kinase domain
|
None
|
0.26
nM
|
|
Binding constant for EGFR(L858R) kinase domain
|
None
|
0.24
nM
|
|
Binding constant for EGFR(L858R,T790M) kinase domain
|
None
|
0.28
nM
|
|
Binding constant for EGFR(L861Q) kinase domain
|
None
|
0.22
nM
|
|
Binding constant for EGFR(S752-I759del) kinase domain
|
None
|
0.19
nM
|
|
Binding constant for EGFR(T790M) kinase domain
|
None
|
0.1
nM
|
|
Binding constant for GAK kinase domain
|
None
|
100.0
nM
|
|
Binding constant for LCK kinase domain
|
None
|
320.0
nM
|
|
Binding constant for RET(M918T) kinase domain
|
None
|
840.0
nM
|
|
Binding constant for YSK4 kinase domain
|
None
|
700.0
nM
|
|
Antiproliferative activity against human HCC827 cells harboring EGFR del E746-A750 mutant after 72 hrs by MTS assay
|
Homo sapiens
|
1.0
nM
|
|
Antiproliferative activity against human NCI-H1975 cells harboring EGFR L858R/T790M mutant after 72 hrs by MTS assay
|
Homo sapiens
|
64.0
nM
|
|
Antiproliferative activity against human A431 cells overexpressing EGFR after 72 hrs by MTS assay
|
Homo sapiens
|
150.0
nM
|
|
Inhibition of EGFR
|
None
|
1.5
nM
|
|
Inhibition of ErbB2
|
None
|
5.0
nM
|
|
Inhibition of ErbB4
|
None
|
10.0
nM
|
|
Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay
|
Homo sapiens
|
0.8
nM
|
|
Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis
|
Homo sapiens
|
0.11
nM
|
|
Inhibition of EGF-stimulated wild type EGFR autophosphorylation expressed in human A549 cells by sandwich ELISA
|
Homo sapiens
|
6.0
nM
|
|
Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA
|
Homo sapiens
|
3.0
nM
|
|
Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.
|
Homo sapiens
|
687.0
nM
|
|
Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.
|
Homo sapiens
|
504.0
nM
|
|
Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.
|
Homo sapiens
|
8.0
nM
|
|
Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.
|
Homo sapiens
|
679.0
nM
|
|
Inhibition of EGFR (unknown origin)
|
Homo sapiens
|
7.4
nM
|
|
Antiproliferative activity against human NCI-H1975 cells expressing EGFR T790M/L858R mutant incubated for 72 hrs by MTS assay
|
Homo sapiens
|
101.0
nM
|
|
Inhibition of GST-tagged human EGFR catalytic domain expressed in insect cells
|
Homo sapiens
|
0.3
nM
|
|
Inhibition of GST-tagged human HER2 catalytic domain expressed in insect cells
|
Homo sapiens
|
30.0
nM
|
|
Inhibition of human EGFR T790M/L858R mutant expressed in mouse Ba/F3 cells
|
Homo sapiens
|
26.0
nM
|
|
Inhibition of human EGFR L858R mutant expressed in mouse Ba/F3 cells
|
Homo sapiens
|
0.4
nM
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging
|
Homo sapiens
|
3.21
%
|
|
Inhibition of human A431 cell-derived EGFR using polyglutamic acid/tyrosine as substrate incubated for 10 mins followed by [32P]ATP addition and measured after 10 mins by beta counting method
|
Homo sapiens
|
15.0
nM
|
|
Inhibition of EGFR (unknown origin)
|
Homo sapiens
|
2.0
nM
|
|
Inhibition of EGFR (unknown origin) assessed as reduction of phosphorylation of polyglutamic acid/tyrosine incubated for 10 mins by beta scintillation counter
|
Homo sapiens
|
0.8
nM
|
|
Inhibition of HER2 (unknown origin) assessed as reduction of phosphorylation of polyglutamic acid/tyrosine incubated for 10 mins by beta scintillation counter
|
Homo sapiens
|
19.0
nM
|
|
Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay
|
Homo sapiens
|
2.7
nM
|
|
Antiproliferative activity against human UCH1 cells measured after 72 hrs by alamar blue assay
|
Homo sapiens
|
80.0
nM
|
|
Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method
|
Homo sapiens
|
0.19
nM
|
|
Binding affinity to wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system by Kinomescan method
|
Homo sapiens
|
100.0
nM
|
|
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate
|
Severe acute respiratory syndrome coronavirus 2
|
19.67
%
|
|
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate
|
Severe acute respiratory syndrome coronavirus 2
|
-67.61
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
0.22
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
-0.23
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
0.22
%
|
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging
|
Chlorocebus sabaeus
|
-0.23
%
|
|
Inhibition of recombinant human N-terminal GST tagged EGFR L858R/T790M double mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay
|
Homo sapiens
|
1.26
nM
|
|
Inhibition of recombinant human N-terminal GST tagged EGFR d746-750 mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay
|
Homo sapiens
|
0.04
nM
|
|
Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay
|
Homo sapiens
|
0.1
nM
|
|
Antiproliferative activity against human PC-9 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay
|
Homo sapiens
|
0.8585
nM
|
|
Antiproliferative activity against human PB1 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay
|
Homo sapiens
|
70.19
nM
|
|
Antiproliferative activity against human NCI-H1975 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay
|
Homo sapiens
|
11.34
nM
|
|
Antiproliferative activity against human HCC827 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay
|
Homo sapiens
|
0.3776
nM
|
|
Antiproliferative activity against mouse BaF3 cells assessed as inhibition of cell growth measured after 72 hrs by CCK-8 assay
|
Mus musculus
|
9.2
nM
|
|